During the past decade, Hospital Nacional Hipolito; Unanue conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 3 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Nacional Hipolito; Unanue" #1 sponsor was "Genentech, Inc." with 2 trials, followed by "Sunovion" with 2 trials sponsored, "Brigham and Women's Hospital" with 1 trials sponsored, "Peruvian Clinical Research" with 1 trials sponsored and "Universidad Peruana Cayetano Heredia" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Nacional Hipolito; Unanue" #1 collaborator was "Hospital Nacional Arzobispo Loayza" with 1 trials as a collaborator, "Hospital Nacional Hipólito Unanue" with 1 trials as a collaborator, "Hospital Nacional Sergio Bernales" with 1 trials as a collaborator, "NeuroThera" with 1 trials as a collaborator and "Socios En Salud Sucursal, Peru" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Nacional Hipolito; Unanue" are "Bipolar Depression" (2 trials), "COVID-19" (1 trials), "COVID-19 Pneumonia" (1 trials), "Influenza" (1 trials) and "Major Depressive Disorder" (1 trials). Many other conditions were trialed in "Hospital Nacional Hipolito; Unanue" in a lesser frequency.

Most popular intervention types in "Hospital Nacional Hipolito; Unanue" are "Drug" (4 trials), "Biological" (1 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Convalescent plasma" (1 trials), "FAST" (1 trials), "Lurasidone" (1 trials) and "MHAA4549A" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Nacional Hipolito; Unanue" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Hospital Nacional Hipolito; Unanue". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Hospital Nacional Hipolito; Unanue, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Nacional Hipolito; Unanue, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".